INSM technical analysis
INSM Technical Analysis
Analysis date
August 6, 2026
Market
NasdaqGS (USD)
Daily cutoff
August 5, 2026
Reliability
Passed
Informational use only. This page is not investment advice.
Data verification
INSM Data Verification
Checking the latest completed daily bar for date and closing-price consistency before indicators are calculated.
- Symbol
- INSM
- Market
- NasdaqGS
- Currency
- USD (US Dollar)
- Latest completed bar
- August 5, 2026
Historical prices are adjusted for corporate actions when applicable. Date and closing-price consistency checks passed for the latest completed daily bar.
| Validation series | Latest Close | Date | Difference | Status |
|---|---|---|---|---|
| Calculation series | 99.02 | August 5, 2026 | - | Verified |
| Verification series | 99.02 | August 5, 2026 | 0.00% | Verified |
Bottom line
INSM Technical Analysis Summary
INSM (Insmed Incorporated) is in a steep correction from its 52-week high near 212.75, trading at 99.02 as of the August 5, 2026 close. Price is below the SMA20 (106.18), SMA50 (104.34), and SMA200 (146.65) on the daily chart, and RSI14 at 35.61 with a negative MACD histogram point to persistent downside momentum. The stock sits close to its 52-week low at 90.39, with the 20-period low at 96.42 acting as near-term support. The weekly chart shows price below the weekly SMA20 (118.37) and SMA50 (146.12) but still above the weekly SMA200 (71.06), so the longer-term uptrend is not fully broken. Elevated volume on the latest daily session and very high weekly volatility, with ATR14 at 12.34% of price, underline the risk around this biopharmaceutical name. The technical picture is bearish until price reclaims the SMA20 zone near 106 on rising volume.
Multi-timeframe dashboard
Multi-Timeframe Technical Dashboard
Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.
Daily (August 5, 2026)
- Trend
- Bearish. Price at 99.02 is below the SMA20 (106.18), the SMA50 (104.34), and the SMA200 (146.65). The SMA200 sits well above price, reflecting the deep drawdown from the 52-week high near 212.75. The SMA20 has moved only slightly above the SMA50, which is a mild positive, but price remains under every major moving average.
- Momentum
- Weak. RSI14 at 35.61 is below the 40 level, showing persistent downside momentum without reaching oversold territory. The MACD line at -2.33 is below the signal line at -1.28, and the histogram at -1.05 is negative, confirming bearish momentum on the daily chart.
- Volatility
- Moderate to elevated. ATR14 at 3.82 equals 3.85% of price. Bollinger Bands (95.70 to 116.66) are reasonably wide, and price at 99.02 is trading near the lower band, consistent with the weak tone.
- Volume
- Elevated. Latest volume of 4,897,400 is 1.86 times the 20-period average (2,629,135), showing heavy participation on the latest session as the stock held near its recent lows.
Assessment
The daily chart is bearish. Price sits below all major moving averages and near the lower Bollinger Band, RSI is below 40, and the MACD is negative. Key support is the 20-period low at 96.42 and then the 60-period low and 52-week low at 90.39. Resistance is the SMA20 at 106.18, followed by the 20-period high at 119.54 and the 60-period high at 122.94. A decisive close below 90.39 would open a new leg lower, while reclaiming the SMA20 zone would be the first sign of stabilization.
Weekly (July 27, 2026 week)
- Trend
- Mixed to bearish. Price at 98.60 for the week of July 27 is below the weekly SMA20 (118.37) and SMA50 (146.12), but remains above the weekly SMA200 (71.06). This keeps the longer-term uptrend intact on a structural basis while the medium-term trend is clearly down.
- Momentum
- Weak. Weekly RSI14 at 37.32 is below 40, pointing to continued selling pressure. The weekly MACD line at -11.84 sits just below the signal line at -11.82, with the histogram at -0.02, indicating that momentum has flattened near the bottom of a steep decline rather than turning positive.
- Volatility
- Very elevated. Weekly ATR14 at 12.16 equals 12.34% of price, reflecting extreme weekly swings. Bollinger Bands (77.00 to 159.74) are very wide, highlighting how far the stock has moved in both directions over the past year.
- Volume
- Below average. Latest weekly volume of 12,306,700 is 77.3% of the 20-week average (15,920,155), indicating somewhat lighter participation in the most recent completed week.
Assessment
The weekly chart shows a steep correction from the 52-week high near 212.75 down to the 52-week low at 90.39. Price is below the weekly SMA20 and SMA50, with weak momentum, but the SMA200 at 71.06 remains well below price, so the multi-year uptrend has not been completely invalidated. The 60-period weekly high at 212.75 and the 20-period high at 166.19 mark major resistance zones, while the 20-period low at 90.39 is the immediate support to watch.
Key indicators
INSM Key Technical Indicators
RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.
| Indicator | Daily | Weekly |
|---|---|---|
| RSI (14) | 35.61 | 37.32 |
| MACD (12, 26, 9) | -2.33 / -1.28 / -1.05 | -11.84 / -11.82 / -0.02 |
| ATR (14) | 3.82 (3.85%) | 12.16 (12.34%) |
| Bollinger Bands (20, 2) | 95.70 - 116.66 | 77.00 - 159.74 |
| SMA (20) | 106.18 | 118.37 |
| SMA (50) | 104.34 | 146.12 |
| SMA (200) | 146.65 | 71.06 |
Price structure
INSM Price Structure and Returns
Price performance across multiple lookback periods and 52-week position.
| Metric | Daily | Weekly |
|---|---|---|
| Current Price | 99.02 | 98.60 |
| 1-Period Return | +0.27% | -7.78% |
| 5-Period Return | -3.98% | -4.62% |
| 20-Period Return | -15.03% | -29.32% |
| 60-Period Return | -2.30% | +33.93% |
| 252-Period Return | -10.99% | +260.12% |
| 52-Week Low | 90.39 | 90.39 |
| 52-Week High | 212.75 | 212.75 |
| 52-Week Position | 7.05% | 6.71% |
Key levels
INSM Support and Resistance Levels
Key price levels based on recent swing highs and lows across daily and weekly timeframes.
| Level | Daily | Weekly |
|---|---|---|
| 20-Period High | 119.54 | 166.19 |
| 20-Period Low | 96.42 | 90.39 |
| 60-Period High | 122.94 | 212.75 |
| 60-Period Low | 90.39 | 70.57 |
Scenarios
INSM Technical Scenarios
Conditions, invalidation triggers, and what to watch for each scenario.
Bullish
Trigger
Price reclaims and holds above the SMA20 at 106.18 and then breaks above the 20-period high at 119.54 with rising volume, signaling a stabilization after the correction.
Invalidation
Price turns back down from the SMA20 area and loses the 20-period low at 96.42, failing to hold any recovery.
What to watch
RSI pushing back above 40 and then 50; the daily MACD histogram turning positive; volume expanding on up days; price holding above the SMA20.
Range-Bound
Trigger
Price continues to oscillate between the 20-period low at 96.42 and the 20-period high at 119.54 as the market digests the large correction from the highs.
Invalidation
A decisive close above 122.94 or below 90.39 with rising volume would signal a new directional move out of the range.
What to watch
RSI staying between 30 and 50; MACD hovering near zero; volume settling back toward the 20-period average.
Bearish
Trigger
Price breaks below the 60-period low and 52-week low at 90.39, opening further downside toward the weekly 60-period low at 70.57.
Invalidation
Price reclaims and holds above the SMA20 at 106.18, confirming the correction is stabilizing rather than accelerating.
What to watch
RSI falling below 30; the daily MACD histogram becoming more negative; volume increasing on down days; any company-specific news that drives a sharp move in this biopharmaceutical stock.
Methodology
Methodology and Limitations
This technical analysis is calculated locally from adjusted OHLCV history. The daily series ends August 5, 2026, and the weekly series ends July 27, 2026 week. The latest completed daily bar is independently checked for date and closing-price consistency. Historical prices are adjusted for corporate actions when applicable. Indicators include Wilder RSI(14), MACD(12,26,9), SMA20/50/200, Wilder ATR(14), Bollinger Bands(20,2), relative volume, multi-period returns, and price-range levels. Support and resistance are descriptive zones, not guaranteed reversal points. Historical patterns do not predict future prices, and this page is not investment advice.
Frequently Asked Questions
This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. INSM (Insmed Incorporated) is a biopharmaceutical company with a volatile price history, and the stock has moved sharply in both directions over the past year. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Market data is checked for date and closing-price consistency before indicators are calculated. Data cutoffs: daily August 5, 2026, weekly July 27, 2026 week. Generated August 6, 2026.
Related Tools
AI Chart Analyzer
Upload a TradingView chart screenshot and get instant AI-powered technical analysis. Identify patterns, support and resistance, and key levels.
Support and Resistance Calculator
Calculate key support and resistance levels for any stock. Identify potential price zones where reversals or breakouts may occur.
RSI Calculator
Calculate the Relative Strength Index for any stock. Determine overbought and oversold conditions with customizable periods.